 Connection
Curtis Coughlin II to Rare Diseases
This is a "connection" page, showing publications Curtis Coughlin II has written about Rare Diseases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.420 |
|
|
|
-
Nolen N, Aartsma-Rus A, Caneva C, Coughlin Ii CR, Cousin MA, Douthwright C, Graessner H, Kim-McManus O, Kuniholm A, Leonard S, Martinsen A, Meserve M, Synofzik M, Yandava B, Yu TW, Demarest S, Paxton RJ. Paying for precision: funding approaches for N-of-1 trials of individualized gene targeted therapies. Orphanet J Rare Dis. 2026 May 21; 21(1).
Score: 0.224
-
Berry SA, Coughlin CR, McCandless S, McCarter R, Seminara J, Yudkoff M, LeMons C. Developing interactions with industry in rare diseases: lessons learned and continuing challenges. Genet Med. 2020 01; 22(1):219-226.
Score: 0.140
-
Shelkowitz E, Schrier Vergano SA, Penon-Portmann M, Wixson G, Beckman E, Campbell T, Mills MR, Kochhar A, Wilfond BS, Trowbridge A, Coughlin CR, Wightman A. New treatments, novel conversations: A need to study the science of communication about treatment options for inborn errors of metabolism. Genet Med. 2026 Jun; 28(6):102581.
Score: 0.056
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|